From: United Kingdom health research analyses and the benefits of shared data
HRCS Research Activity Group | 2004/2005 | 2009/2010 | 2014 (HRAF) | Difference in 2014 (£) | Difference in 2014 (%) | |||||
---|---|---|---|---|---|---|---|---|---|---|
Value (£m) | % | Value (£m) | % | Value (£m) | % | vs. 04/05 | vs. 09/10 | vs. 04/05 | vs. 09/10 | |
1 Underpinning | 401.7 | 33.6% | 488.7 | 27.6% | 453.5 | 23.9% | 51.8 | –35.2 | –9.7% | –3.7% |
2 Aetiology | 414.4 | 34.7% | 563.1 | 31.8% | 558.4 | 29.4% | 144. | –4.7 | –5.2% | –2.3% |
3 Prevention | 29.6 | 2.5% | 66.4 | 3.7% | 101.5 | 5.4% | 71.9 | 35.2 | 2.9% | 1.6% |
4 Detection and Diagnosis | 62.9 | 5.3% | 129.9 | 7.3% | 189.0 | 10.0% | 126.1 | 59.1 | 4.7% | 2.6% |
5 Treatment Development | 102.9 | 8.6% | 189.3 | 10.7% | 228.8 | 12.1% | 126.0 | 39.6 | 3.5% | 1.4% |
6 Treatment Evaluation | 99.0 | 8.3% | 151.5 | 8.5% | 179.0 | 9.4% | 79.9 | 27.5 | 1.1% | 0.9% |
7 Disease Management | 27.7 | 2.3% | 57.3 | 3.2% | 71.4 | 3.8% | 43.7 | 14.1 | 1.4% | 0.5% |
8 Health Services | 56.2 | 4.7% | 126.1 | 7.1% | 114.9 | 6.1% | 58.7 | –11.2 | 1.4% | –1.1% |
Grand Total | 1194.3 | 100% | 1772.3 | 100% | 1896.5 | 100% | 702.1 | 124.2 | 0.0% | 0.0% |